MAGICAL MEDICINE: HOW TO MAKE AN ILLNESS ... - Invest in ME
MAGICAL MEDICINE: HOW TO MAKE AN ILLNESS ... - Invest in ME
MAGICAL MEDICINE: HOW TO MAKE AN ILLNESS ... - Invest in ME
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
2<br />
CONTENTS<br />
Executive Summary, <strong>in</strong>clud<strong>in</strong>g summary of documented organic pathology……………………. 4<br />
Introduction and source of <strong>in</strong>formation……………………………………………………………….. 7<br />
The difference between <strong>ME</strong>/CFS and “CFS/<strong>ME</strong>”…………………………………………………….. 10<br />
No cure for <strong>ME</strong>/CFS ……………………………………………………………………………………... 14<br />
<strong>ME</strong>/CFS causes death ……………………………………………………………………………………. 15<br />
Section 1: Background to the MRC PACE Trial……………………………………………………… 18<br />
The Wessely School perspective ………………………………………………………………………… 18<br />
The PACE Trial Pr<strong>in</strong>cipal <strong>Invest</strong>igators (PIs) ………………………………………………………….. 30<br />
Flawed studies by the Wessely School………………………………………………………………….. 36<br />
The MRC secret files on CFS/<strong>ME</strong>……………………………………………………………………….. 44<br />
The def<strong>in</strong>ition of CBT/GET used <strong>in</strong> the PACE Trial ………………………………………………….. 48<br />
A “CBT model of CFS/<strong>ME</strong>”……………………………………………………………………………… 49<br />
The troubl<strong>in</strong>g issue of CBT/GET as the sole <strong>in</strong>tervention……………………………………………. 51<br />
Dutch Report show<strong>in</strong>g that CBT/GET is not helpful <strong>in</strong> <strong>ME</strong>/CFS…………………………………… 51<br />
The Wessely School’s attempts to re‐classify <strong>ME</strong>/CFS as a mental disorder………………………. 53<br />
The Wessely School’s attempts to reclassify IBS as a mental disorder………………………………. 56<br />
The Wessely School’s attempts to reclassify fibromyalgia as a mental disorder…………………… 57<br />
UNUMProvident’s policy that underlies the PACE Trial…………………………………………….. 60<br />
The Woodstock connection………………………………………………………………………………. 60<br />
Symptoms or sickness?…………………………………………………………………………………… 62<br />
The ignor<strong>in</strong>g of patients’ experience……………………………………………………………………. 75<br />
Illustrations of patients’ experiences of psychiatric management…………………………………… 78<br />
Illustrations of the effects of dissem<strong>in</strong>ation of mis<strong>in</strong>formation………………………………………. 83<br />
CFS/<strong>ME</strong> Cl<strong>in</strong>ical & Research Network Collaboration………………………………………………… 86<br />
International experts’ concerns about CBT/GET <strong>in</strong> <strong>ME</strong>/CFS provided for the High Court ……... 88<br />
Refusal of PIs to heed the biomedical science is caus<strong>in</strong>g <strong>in</strong>creas<strong>in</strong>g concern……………………….. 94<br />
Section 2: Counter‐evidence: the biomedical basis of <strong>ME</strong>/CFS……………………………………. 98<br />
<strong>ME</strong>/CFS is not “medically unexpla<strong>in</strong>ed fatigue” ……………………………………………………... 99<br />
Evidence that the Pr<strong>in</strong>cipal <strong>Invest</strong>igators chose to ignore ……………………………………………. 106<br />
Documented pathology <strong>in</strong> <strong>ME</strong>/CFS that contra‐<strong>in</strong>dicates the use of GET………………………….. 110<br />
Documented muscle abnormalities <strong>in</strong> <strong>ME</strong>/CFS……………………………………………………….. 111<br />
Documented cardiovascular abnormalities <strong>in</strong> <strong>ME</strong>/CFS………………………………………………. 119<br />
Documented neurological abnormalities <strong>in</strong> <strong>ME</strong>/CFS…………………………………………………. 139<br />
Documented abnormalities shown on neuroimag<strong>in</strong>g <strong>in</strong> <strong>ME</strong>/CFS…………………………………… 145<br />
Documented neuroendocr<strong>in</strong>e abnormalities <strong>in</strong> <strong>ME</strong>/CFS……………………………………………… 148<br />
Documented evidence of <strong>in</strong>flammation <strong>in</strong> <strong>ME</strong>/CFS…………………………………………………… 151<br />
Note on <strong>in</strong>flammation……………………………………………………………………………………... 154<br />
Documented immune system abnormalities <strong>in</strong> <strong>ME</strong>/CFS……………………………………………… 155<br />
Documented hair loss <strong>in</strong> <strong>ME</strong>/CFS……………………………………………………………………….. 170<br />
Documented gastro‐<strong>in</strong>test<strong>in</strong>al abnormalities <strong>in</strong> <strong>ME</strong>/CFS……………………………………………... 171<br />
Documented liver and spleen problems <strong>in</strong> <strong>ME</strong>/CFS…………………………………………….…….. 171<br />
Documented respiratory abnormalities <strong>in</strong> <strong>ME</strong>/CFS…………………………………………………… 172<br />
Documented abnormal gene expression <strong>in</strong> <strong>ME</strong>/CFS………………………………………………….. 173<br />
Documented ocular abnormalities <strong>in</strong> <strong>ME</strong>/CFS………………………………………………………… 177<br />
Documented <strong>in</strong>volvement of viruses <strong>in</strong> <strong>ME</strong>/CFS……………………………………………………… 178<br />
The role of viruses <strong>in</strong> <strong>ME</strong>/CFS…………………………………………………………………………… 192<br />
Objective signs <strong>in</strong> <strong>ME</strong>/CFS……………………………………………………………………………….. 210<br />
Documented signs and symptoms <strong>in</strong> <strong>ME</strong>/CFS………………………………………………………… 211<br />
Documented <strong>in</strong>ternational concerns about CBT/GET for patients with <strong>ME</strong>/CFS…………………. 214<br />
Professor White’s Presentation <strong>in</strong> Bergen on 20 th October 2009………………………………………. 217<br />
Defiance of science is rewarded <strong>in</strong> the UK……………………………………………………………… 221